Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Cortex initiates enrollment in clinical trial of CX-717 in opiate induced respiratory depression

April 3, 2008

Levodopa effective when added to behavioral therapy for cocaine dependence

March 31, 2008

Molecular processes identified in anxiety and alcoholism comorbidity

March 25, 2008

Merck Serono launches Cyanokit for cyanide poisoning in Japan

March 20, 2008

Cortex receives German approval for two Ampakine CX-717 trials

March 10, 2008

Akela initiate phase I clinical trial of Edacs abuse deterrent opioid

March 10, 2008

PharmAthene reports results from initial pharmacokinetic studies of Protexia

March 10, 2008

Neurokinin 1 receptor potential target for the treatment of alcoholism

March 7, 2008

Evotec commences phase II smoking cessation trial with EVT-302

Feb. 29, 2008

Protectan CBLB-502 significantly decreases adverse effects of chemotherapy in mice

Feb. 20, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...